green ribbon

Election Software Company Secures £700k Boost

A Derry/Londonderry-based election software company has secured a £700,000 investment which will facilitate further growth in the UK and international markets.

The team developed the Modern Polling SaaS platform, which initially focused on transforming the front-end voter and polling staff experience, by digitalising the check-in process.

Since then, the platform has expanded its capabilities and now offers real-time reporting and analytics on election day.

This funding round was led by local business angel investors, including members of the Halo Business Angel Network (HBAN), whose investment was matched by Co-Fund NI and backed by existing shareholder Capital Crescent.

Ann-Marie Slavin, director of strategy at Modern Democracy, said: "Backed by a Government-led programme of change and accelerated by the Covid-19 pandemic, the demand for digital transformation at polling stations is increasing.

VascVersa is an early-stage spin-out from Queen’s University specialising in “visionary” technology for vascular regeneration.

In its second seed round, it has raised the money from Co-Fund NI, managed by Clarendon Fund Managers; QUBIS, the commercialisation arm of Queen’s University; the Innovation Investment Fund, and angel investors from the Halo & Business Angel Network.

The first target is “chronic non-healing wounds” which includes diabetic foot ulcers.

Aidan Courtney, chairman of VascVersa, added: “We have received tremendous support from our investors and Queen’s University Belfast which will allow the company to expand its Belfast research facilities and develop new products based on its groundbreaking technology.” Stuart Gaffikin, investment manager at Clarendon Fund Managers, said Co-Fund NI was “delighted” to support VascVersa.

In 2016 he co-founded Roslin Cells, a provider of stem cells and developer of new cell therapies.

He restructured Roslin Cells to create two separate spin-out businesses and subsequently became CEO of Censo Biotechnologies.